Zilucoplan

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 77 publications

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Real-world effectiveness and safety of zilucoplan in patients with anti-AChR myasthenia gravis: A retrospective cohort study in France.

Journal: Journal of neuromuscular diseases
Published: March 29, 2026

Rapid Symptomatic Improvement and Long-Term Minimal Symptom Expression in a Myasthenia Gravis Patient Treated With Zilucoplan Without Maintenance Cholinesterase Inhibitors, Corticosteroids, or Immunosuppressants: A Case Report.

Rapid Symptomatic Improvement and Long-Term Minimal Symptom Expression in a Myasthenia Gravis Patient Treated With Zilucoplan Without Maintenance Cholinesterase Inhibitors, Corticosteroids, or Immunosuppressants: A Case Report.

Journal: Cureus
Published: January 28, 2026

Authors' reply to comment letter on ZILU25 study.

Authors' reply to comment letter on ZILU25 study.

Journal: Journal of the neurological sciences
Published: January 13, 2026

Novel Therapies for Generalized Myasthenia Gravis: Insights Into FcRn and Complement Inhibition.

Novel Therapies for Generalized Myasthenia Gravis: Insights Into FcRn and Complement Inhibition.

Journal: American journal of therapeutics
Published: January 08, 2026

Letter to the editor: Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Letter to the editor: Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Journal: Journal of the neurological sciences
Published: January 08, 2026

Efficacy and safety of complement inhibitors and FcRn blockers in generalized AChR antibody-positive myasthenia gravis: a meta-analysis.

Efficacy and safety of complement inhibitors and FcRn blockers in generalized AChR antibody-positive myasthenia gravis: a meta-analysis.

Journal: Journal of neurology
Published: January 06, 2026

Letter to editor: Early real-life experience on zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Letter to editor: Early real-life experience on zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study.

Journal: Journal of the neurological sciences
Published: January 02, 2026

Body weight distribution of US patients with myasthenia gravis.

Body weight distribution of US patients with myasthenia gravis.

Journal: Journal of medical economics
Published: December 21, 2025

Comments on ZILU25: Real-world efficacy of Zilucoplan in generalized myasthenia gravis.

Comments on ZILU25: Real-world efficacy of Zilucoplan in generalized myasthenia gravis.

Journal: Journal of the neurological sciences
Published: December 11, 2025

Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG).

Discovery of Zilucoplan: A Complement C5 Inhibitor for Treatment of Anti-Acetylcholine Receptor (AChR) Antibody-Positive Generalized Myasthenia Gravis (gMG).

Journal: Journal of medicinal chemistry
Published: December 11, 2025

Zilucoplan is effective for ravulizumab-refractory generalized myasthenia gravis with the C5 p.Arg885His variant: a case report.

Zilucoplan is effective for ravulizumab-refractory generalized myasthenia gravis with the C5 p.Arg885His variant: a case report.

Journal: Neuromuscular disorders : NMD
Published: November 09, 2025

Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis.

Assessing the Value Contribution of Vyvgart® (Efgartigimod Alfa) in the Treatment of Generalized Myasthenia Gravis with Acetylcholine Receptor Antibody in Spain Through Multi-criteria Decision Analysis.

Journal: Advances in therapy
Published: October 24, 2025
Showing 1-12 of 77

Last Updated: 04/28/2026